Crohn's Disease (CD)

Ulcerative Colitis (UC)

IBD - Management

There are however some key differences which are highlighted in table below:

Crohn's disease (CD) Ulcerative colitis (UC)
Features Diarrhoea usually non-bloody
Weight loss more prominent
Upper gastrointestinal symptoms, mouth ulcers, perianal disease
Abdominal mass palpable in the right iliac fossa Bloody diarrhoea more common
Abdominal pain in the left lower quadrant
Tenesmus
Extra-intestinal Gallstones are more common secondary to reduced bile acid reabsorption
Oxalate renal stones* Primary sclerosing cholangitis more common
Complications Obstruction, fistula, colorectal cancer Risk of colorectal cancer high in UC than CD
Pathology Lesions may be seen anywhere from the mouth to anus
Skip lesions may be present Inflammation always starts at rectum and never spreads beyond ileocaecal valve
Continuous disease
Histology Inflammation in all layers from mucosa to serosa
• increased goblet cells
• granulomas No inflammation beyond submucosa (unless fulminant disease) - inflammatory cell infiltrate in lamina propria
• neutrophils migrate through the walls of glands to form crypt abscesses
• depletion of goblet cells and mucin from gland epithelium
• granulomas are infrequent
Endoscopy Deep ulcers, skip lesions- 'cobble-stone' appearance Widespread ulceration with preservation of adjacent mucosa which has the appearance of polyps ('pseudopolyps')
Radiology Small bowel enema
• high sensitivity and specificity for examination of the terminal ileum
• strictures: 'Kantor's string sign'
• proximal bowel dilation
• 'rose thorn' ulcers
• fistulae Barium enema
• loss of haustrations
• superficial ulceration, 'pseudopolyps'
• long standing disease: colon is narrow and short -'drainpipe colon'

Extra-intestinal' features

Questions regarding the 'extra-intestinal' features of inflammatory bowel disease are common:

Antineutrophil cytoplasmic antibody (ANCA), esp. p-ANCA,  is positive in UC and negative and CD.

Antisaccharomyces cerevesiae antibody (ASCA) is positive in CD and negative in UC.

All IBD is associated with anaemia and can lead to colon cancer.

Associated with increased platelet count (PLT) and plateletcrit (PCT), but decreased mean platelet volume (MPV)

According to a meta-analysis (79 studies; >21,500 participants), compared with healthy individuals, patients with IBD had a significantly higher PLT (weighted mean difference [WMD] 69.91 [62.17-77.64×109/L; p<0.001) and PCT (WMD 0.046% [0.031%-0.061%]; p<0.001). However, patients with IBD had a significantly decreased MPV (WMD −0.912 [−1.086 to −0.739 fL]; p<0.001).

Ref: https://pubmed.ncbi.nlm.nih.gov/38961334/

When should screening occur?

After 8 to 10 years of colonic involvement, with colonoscopy every 1 to 2 years.

Complications